Reducing Chinese API Imports Key For Indian Pharma Growth, Says IPA
IPA Lays Out ‘Vision 2030’ For Indian Pharma Sector
The Indian pharma sector fears that policy shifts by the Chinese government could result in extreme price shifts for certain molecules. • Source: Shutterstock
